Increased Eligibility for Treatment of Chronic Hepatitis C Infection with Shortened Duration of Therapy: Implications for Access to Care and Elimination Strategies in Canada

Autor: Sergio M Borgia, Adenike Rowaiye
Jazyk: angličtina
Rok vydání: 2015
Předmět:
Zdroj: Canadian Journal of Gastroenterology and Hepatology, Vol 29, Iss 3, Pp 125-129 (2015)
Druh dokumentu: article
ISSN: 2291-2789
2291-2797
DOI: 10.1155/2015/591260
Popis: BACKGROUND: All oral, highly effective direct-acting antiviral combinations, such as sofosbuvir-ledipasvir, have recently been licensed in Canada but cost as much as $67,000 for a 12-week course of therapy, representing a major economic barrier to predominately single-payer health care systems such as that found in Ontario. In hepatitis C virus (HCV) genotype 1 noncirrhotic patients with a baseline viral load of
Databáze: Directory of Open Access Journals
Externí odkaz: